journal article·2026-01-08Open access

Plant-Based Production and Immunogenicity Evaluation of a GCN4pII-Fused PCV2d Cap Protein in Mice

Thuong Thi Ho, Hoai Thu Tran, Hien Thi Thu Nguyen, My Tra Le, Ha Hoang Chu, Ngoc Bich Pham, Van Thi Pham

Applied Sciences· Volume 16· Issue 2

Abstract

Porcine circovirus 2 (PCV2) is a DNA virus that is classified in the genus Circovirus of the Circoviridae family, which is a causative agent of Porcine Circovirus-Associated disease (PCVAD). PCVAD continues to cause substantial losses in global pig farming, with PCV2d being the prevalent genotype worldwide, including in Vietnam. In this study, we focused on generating a recombinant PCV2d Cap protein fused to the GCN4pII motif (Cap2d-pII) in a plant-based system and evaluating its immunogenicity. The Cap2d-pII gene was cloned into a plant expression vector and introduced into Agrobacterium tumefaciens for transient expression in Nicotiana benthamiana leaves. Western blot analysis confirmed the high accumulation of the Cap2d-pII protein, which was purified by Immobilized affinity chromatography and used for immunizing mice. ELISA and immunoperoxidase monolayer assay results demonstrated that immunization with the recombinant protein elicited robust humoral and cellular immune responses. At 56 days after immunization, mice vaccinated with the Cap2d-pII protein generated PCV2d-specific IgG titers and IFN-γ responses that were consistent with those in mice receiving the commercial inactivated vaccine. These observations confirm that the plant-expressed Cap2d-pII antigen effectively activates both antibody- and T cell-mediated immune pathways. Collectively, this study identifies the Cap2d-pII protein as a promising plant-derived vaccine candidate for the development of effective and affordable PCV2d subunit vaccines.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Transgenic Plants and Applications · Animal Virus Infections Studies · Toxin Mechanisms and Immunotoxins

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Biology, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet, Ha Noi 100000, Vietnam

Graduate University of Science and Technology, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet, Ha Noi 100000, Vietnam

Funding

Vietnam Academy of Science and Technology

References (74)

Show source-provided references
1. A very small porcine virus with circular single-stranded DNA10.1038/295064a0 ↗
2. Porcine circovirus 2 (PCV2) population study in experimentally infected pigs developing PCV2-systemic disease or a subclinical infection10.1038/s41598-020-74627-3 ↗
3. Immune responses and vaccine-induced immunity against porcine circovirus type 210.1016/j.vetimm.2010.03.025 ↗
4. The natural history of porcine circovirus type 2: From an inoffensive virus to a devastating swine disease?10.1016/j.vetmic.2012.12.033 ↗
5. Porcine circovirus type 2 and porcine circovirus-associated disease10.1111/j.1939-1676.2009.0389.x ↗
6. Porcine dermatitis and nephropathy syndrome (PDNS): An overview of the disease
7. Porcine circovirus: A historical perspective10.1177/0300985814521245 ↗
8. Transcriptional analysis of porcine circovirus type 210.1006/viro.2002.1733 ↗
9. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein10.1099/0022-1317-81-9-2281 ↗
10. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins10.1016/S0264-410X(03)00503-6 ↗
11. Global molecular genetic analysis of porcine circovirus type 2 (PCV2) sequences confirms the presence of four main PCV2 genotypes and reveals a rapid increase of PCV2d10.1099/vir.0.000100 ↗
12. Phylodynamic analysis of porcine circovirus type 2 reveals global waves of emerging genotypes and the circulation of recombinant forms10.1016/j.ympev.2016.04.028 ↗
13. Mao, Q., Zhang, W., Ma, S., Qiu, Z., Li, B., Xu, C., He, H., Fan, S., Wu, K., and Chen, J. (2021). Fusion expression and immune effect of PCV2 cap protein tandem multiantigen epitopes with CD154/GM-CSF. Vet. Sci., 8.10.3390/vetsci8100211 ↗
14. Genotypic diversity of porcine circovirus type 2 (PCV2) and genotype shift to PCV2d in Korean pig population10.1016/j.virusres.2016.11.015 ↗
15. Franzo, G., and Segalés, J. (2018). Porcine circovirus 2 (PCV-2) genotype update and proposal of a new genotyping methodology. PLoS ONE, 13.10.1371/journal.pone.0208585 ↗
16. Weissenbacher-Lang, C., Kristen, T., Mendel, V., Brunthaler, R., Schwarz, L., and Weissenböck, H. (2020). Porcine circovirus type 2 (PCV2) genotyping in Austrian pigs in the years 2002 to 2017. BMC Vet. Res., 16.10.1186/s12917-020-02413-4 ↗
17. Porcine circovirus genotypes and their copathogens in pigs with respiratory disease in southern provinces of Vietnam10.1007/s00705-020-04878-y ↗
18. Ten years of PCV2 vaccines and vaccination: Is eradication a possibility?10.1016/j.vetmic.2016.10.002 ↗
19. Kang, S.-J., Bae, S.-M., Lee, H.-J., Jeong, Y.-J., Lee, M.-A., You, S.-H., Lee, H.-S., Hyun, B.-H., Lee, N., and Cha, S.-H. (2021). Porcine circovirus (PCV) genotype 2d-based virus-like particles (VLPs) induced broad cross-neutralizing antibodies against diverse genotypes and provided protection in dual-challenge infection of a PCV2d virus and a type 1 porcine reproductive and respiratory syndrome virus (PRRSV). Pathogens, 10.10.3390/pathogens10091145 ↗
20. Construction of a Lactobacillus plantarum strain expressing the capsid protein of porcine circovirus type 2d (PCV2d) as an oral vaccine10.1007/s12088-019-00827-9 ↗
21. Evaluation of formulation and immunogenicity of porcine circovirus type 2d (PCV2d) vaccine for needle-free intradermal route injection10.4142/jvs.24323 ↗
22. Recent developments in therapeutic protein expression technologies in plants10.1007/s10529-014-1699-7 ↗
23. Pogue, G.P., and Holzberg, S. (2012). Transient virus expression systems for recombinant protein expression in dicot- and monocotyledonous plants. Plant Science, InTech.
24. Plant-produced vaccines: Promise and reality10.1016/j.drudis.2008.10.002 ↗
25. Edible vaccines against veterinary parasitic diseases—Current status and future prospects10.1016/j.vaccine.2013.02.022 ↗
26. Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses10.1016/j.vetmic.2016.11.029 ↗
27. Efficacy and safety of a recombinant plant-based adjuvanted COVID-19 vaccine10.1056/NEJMoa2201300 ↗
28. Plant molecular farming in the wake of the closure of Medicago Inc10.1038/s41587-023-01812-w ↗
29. Immunogenicity of plant-produced porcine circovirus-like particles in mice10.1111/pbi.13097 ↗
30. Porcine circovirus 2 capsid protein produced in N. benthamiana forms virus-like particles that elicit production of virus-neutralizing antibodies in guinea pigs10.1016/j.nbt.2021.02.005 ↗
31. Efficacy test of a plant-based porcine circovirus type 2 (PCV2) virus-like particle vaccine against four PCV2 genotypes (2a, 2b, 2d, and 2e) in pigs10.1016/j.vetmic.2022.109512 ↗
32. Field evaluation of novel plant-derived porcine circovirus type 2 vaccine related to subclinical infection10.1002/vms3.1256 ↗
33. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants10.1126/science.8248779 ↗
34. Ho, T.T., Nguyen, G.T., Pham, N.B., Le, V.P., Trinh, T.B.N., Vu, T.H., Phan, H.T., Conrad, U., and Chu, H.H. (2020). Plant-derived trimeric CO-26K-equivalent epitope induced neutralizing antibodies against porcine epidemic diarrhea virus. Front. Immunol., 11.10.3389/fimmu.2020.02152 ↗
35. Ho, T.T., Trinh, V.T., Tran, H.X., Le, P.T.T., Nguyen, T.T., Hoang, H.T.T., Pham, M.D., Conrad, U., Pham, N.B., and Chu, H.H. (2022). The immunogenicity of plant-based COE-GCN4pII protein in pigs against the highly virulent porcine epidemic diarrhea virus strain from genotype 2. Front. Vet. Sci., 9.10.3389/fvets.2022.940395 ↗
36. Nanodiamond enhances immune responses in mice against recombinant HA/H7N9 protein10.1186/s12951-017-0305-2 ↗
37. Dose translation from animal to human studies revisited10.1096/fj.07-9574LSF ↗
38. Structural studies of porcine circovirus type 2 capsid reveal T=1 icosahedral assembly
39. Cryo-EM structure of porcine circovirus 2 virus-like particle at 2.3 Å resolution
40. Genetic and immunogenicity analysis of porcine circovirus type 2 strains isolated in Central China10.1007/s00705-017-3685-6 ↗
41. Production of Escherichia coli-based virus-like particle vaccine against porcine circovirus type 2 challenge in piglets: Structure characterization and protective efficacy validation10.1016/j.jbiotec.2016.02.025 ↗
42. Sobczak, J.M., Barkovska, I., Balke, I., Rothen, D.A., Mohsen, M.O., Skrastina, D., Ogrina, A., Martina, B., Jansons, J., and Bogans, J. (2024). Identifying key drivers of efficient B cell responses: On the role of T help, antigen-organization, and Toll-like receptor stimulation for generating a neutralizing anti-dengue virus response. Vaccines, 12.10.3390/vaccines12060661 ↗
43. Neutralizing immune responses induced by oligomeric H5N1-hemagglutinins from plants10.1186/s13567-017-0458-x ↗
44. Pham, V.T., Ho, T.T., Phan, H.T., Le, T.H., Pham, N.B., Conrad, U., Vu, T.H., and Chu, H.H. (2019). A plant-based artificial haemagglutinin (A/H5N1) strongly induced neutralizing immune responses in mice. Appl. Sci., 9.10.3390/app9214605 ↗
45. A plant-based oligomeric CD2v extracellular domain antigen exhibits equivalent immunogenicity to the live attenuated vaccine ASFV-G-∆I177L10.1007/s00430-024-00804-0 ↗
46. Nuclear localization of the porcine circovirus type 2 capsid protein
47. Nuclear localization signal regulates porcine circovirus type 2 capsid protein nuclear export through phosphorylation10.1016/j.virusres.2017.12.012 ↗
48. Epitope mapping of the major capsid protein of porcine circovirus type 2
49. Antigenic differences among porcine circovirus type 2 strains
50. High-level expression and immunogenicity of porcine circovirus type 2b capsid protein without nuclear localization signal expressed in Hansenula polymorpha10.1016/j.biologicals.2017.11.003 ↗
51. Deletion of the single putative N-glycosylation site of the porcine circovirus type 2 Cap protein enhances specific immune responses by DNA immunisation in mice10.1016/j.tvjl.2011.08.005 ↗
52. Plant protein glycosylation10.1093/glycob/cww023 ↗
53. Vertebrate protein glycosylation: Diversity, synthesis and function10.1038/nrm3383 ↗
54. The intrinsic and extrinsic effects of N-linked glycans on glycoproteostasis10.1038/nchembio.1651 ↗
55. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli10.1016/j.jbiotec.2016.01.017 ↗
56. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development10.1007/s00253-012-4015-2 ↗
57. ELPylated haemagglutinins produced in tobacco plants induce potentially neutralizing antibodies against H5N1 viruses in mice10.1111/pbi.12049 ↗
58. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice10.1016/j.vaccine.2012.11.062 ↗
59. Isolation and Identification of Porcine Circovirus 2 from Cases of Respiratory Disease and Postweaning Multisystemic Wasting Syndrome in Pigs10.14737/journal.aavs/2014/2.6.365.368 ↗
60. Isolation and Characterization of Porcine Circovirus Type 2 from Pigs Showing Signs of Post-Weaning Multisystemic Wasting Syndrome in the Netherlands10.1080/01652176.2000.9695049 ↗
61. Rajkhowa, T.K. (2008). Studies on Pathology and Diagnosis of PCV2 Associated Diseases. [Ph.D. Thesis, Deemed University, Indian Veterinary Research Institute (IVRI)].
62. Application of an immunoperoxidase monolayer assay for the detection of arboviral antibodies10.1016/S0166-0934(97)02185-X ↗
63. A comparative study of an indirect fluorescent antibody test and an immunoperoxidase monolayer assay for the diagnosis of porcine proliferative enteropathy10.1177/104063870201400512 ↗
64. Meerts, P., Misinzo, G., Lefebvre, D., Nielsen, J., Bøtner, A., Kristensen, C.S., and Nauwynck, H.J. (2006). Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet. Res., 2.10.1186/1746-6148-2-6 ↗
65. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs10.1016/j.vetmic.2007.06.004 ↗
66. Comparison of the immunoperoxidase monolayer assay and three commercial ELISAs for detection of antibodies against porcine circovirus type 210.1016/j.tvjl.2014.05.025 ↗
67. Li, W., Li, J., Dai, X., Liu, M., Khalique, A., Wang, Z., Zeng, Y., Zhang, D., Ni, X., and Zeng, D. (2022). Surface display of porcine circovirus type 2 antigen protein Cap on the spores of Bacillus subtilis 168: An effective mucosal vaccine candidate. Front. Immunol., 13.10.3389/fimmu.2022.1007202 ↗
68. Construction of polycistronic baculovirus surface display vectors to express the PCV2 Cap(D41) protein and analysis of its immunogenicity in mice and swine10.1186/s13567-020-00836-3 ↗
69. Yang, Y., Xu, Z., Tao, Q., Xu, L., Gu, S., Huang, Y., Liu, Z., Zhang, Y., Wen, J., and Lai, S. (2024). Construction of recombinant pseudorabies virus expressing PCV2 Cap, PCV3 Cap, and IL-4: Investigation of their biological characteristics and immunogenicity. Front. Immunol., 15.10.3389/fimmu.2024.1339387 ↗
70. Glycosylation and the immune system10.1126/science.291.5512.2370 ↗
71. Glycoimmunology: Ignore at your peril!10.1111/j.1600-065X.2009.00800.x ↗
72. Post-translationally modified T cell epitopes: Immune recognition and immunotherapy10.1007/s00109-009-0526-4 ↗
73. Carbohydrates and T cells: A sweet twosome10.1016/j.smim.2013.05.005 ↗
74. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation10.1038/s41467-020-16567-0 ↗